These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2018797)
1. Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor. Dunning AM; Houlston R; Frostegård J; Revill J; Nilsson J; Hamsten A; Talmud P; Humphries S Biochim Biophys Acta; 1991 Apr; 1096(3):231-7. PubMed ID: 2018797 [TBL] [Abstract][Full Text] [Related]
2. Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia. Korhonen T; Savolainen MJ; Kesäniemi YA Atherosclerosis; 1999 Sep; 146(1):1-10. PubMed ID: 10487480 [TBL] [Abstract][Full Text] [Related]
3. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979 [TBL] [Abstract][Full Text] [Related]
4. Primary structure comparison of the proposed low density lipoprotein (LDL) receptor binding domain of human and pig apolipoprotein B: implications for LDL-receptor interactions. Ebert DL; Maeda N; Lowe SW; Hasler-Rapacz J; Rapacz J; Attie AD J Lipid Res; 1988 Nov; 29(11):1501-9. PubMed ID: 3241126 [TBL] [Abstract][Full Text] [Related]
5. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. Ludwig EH; Hopkins PN; Allen A; Wu LL; Williams RR; Anderson JL; Ward RH; Lalouel JM; Innerarity TL J Lipid Res; 1997 Jul; 38(7):1361-73. PubMed ID: 9254062 [TBL] [Abstract][Full Text] [Related]
6. A very conservative region of ApoB-100 in the putative binding region to the LDL receptor in the Toulouse population. Avoustin P; Mostachi H; Perret B; Cambou JP; Cambien F; de Préval C Hum Genet; 1992 Dec; 90(4):460-3. PubMed ID: 1483706 [TBL] [Abstract][Full Text] [Related]
7. Influence of polymorphism Q3405E and mutation A3371V in the apolipoprotein B gene on LDL receptor binding. Gaffney D; Hoffs MS; Cameron IM; Stewart G; O'Reilly DS; Packard CJ Atherosclerosis; 1998 Mar; 137(1):167-74. PubMed ID: 9568749 [TBL] [Abstract][Full Text] [Related]
8. The fractional catabolic rate of low density lipoprotein in normal individuals is influenced by variation in the apolipoprotein B gene: a preliminary study. Houlston RS; Turner PR; Revill J; Lewis B; Humphries SE Atherosclerosis; 1988 May; 71(1):81-5. PubMed ID: 2897860 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody 5A binds apolipoprotein B-48 and inhibits the low density lipoprotein-receptor interaction. Corsini A; Fantappiè S; Marcovina S; Granata A; Fumagalli R; Catapano AL Biochem Biophys Res Commun; 1989 Aug; 162(3):908-15. PubMed ID: 2475112 [TBL] [Abstract][Full Text] [Related]
10. Complete protein sequence and identification of structural domains of human apolipoprotein B. Knott TJ; Pease RJ; Powell LM; Wallis SC; Rall SC; Innerarity TL; Blackhart B; Taylor WH; Marcel Y; Milne R Nature; 1986 Oct 23-29; 323(6090):734-8. PubMed ID: 3773997 [TBL] [Abstract][Full Text] [Related]
11. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor. März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047 [TBL] [Abstract][Full Text] [Related]
12. Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene. Demant T; Houlston RS; Caslake MJ; Series JJ; Shepherd J; Packard CJ; Humphries SE J Clin Invest; 1988 Sep; 82(3):797-802. PubMed ID: 2901432 [TBL] [Abstract][Full Text] [Related]
13. Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production. Millar JS; Maugeais C; Ikewaki K; Kolansky DM; Barrett PH; Budreck EC; Boston RC; Tada N; Mochizuki S; Defesche JC; Wilson JM; Rader DJ Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):560-5. PubMed ID: 15637307 [TBL] [Abstract][Full Text] [Related]
14. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. Pease RJ; Milne RW; Jessup WK; Law A; Provost P; Fruchart JC; Dean RT; Marcel YL; Scott J J Biol Chem; 1990 Jan; 265(1):553-68. PubMed ID: 1688435 [TBL] [Abstract][Full Text] [Related]
15. A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor. Lund-Katz S; Ibdah JA; Letizia JY; Thomas MT; Phillips MC J Biol Chem; 1988 Sep; 263(27):13831-8. PubMed ID: 3138240 [TBL] [Abstract][Full Text] [Related]
16. Reduction of LDL production rate in ileal bypassed rabbits treated with lovastatin. Lombardi P; Maggi FM; Maione G; Catapano AL Pharmacol Res; 1991 Feb; 23(2):129-37. PubMed ID: 2062789 [TBL] [Abstract][Full Text] [Related]
17. Locating a low density lipoprotein-targeting domain of human apolipoprotein B-100 by expressing a minigene construct in transgenic mice. Xiong WJ; Zsigmond E; Gotto AM; Lei KY; Chan L J Biol Chem; 1991 Nov; 266(31):20893-8. PubMed ID: 1939140 [TBL] [Abstract][Full Text] [Related]
18. Presence of an extended duplication in the putative low-density-lipoprotein receptor-binding domain of apolipoprotein B. Cloning and characterization of the domain in salmon. Babin PJ; Deryckere F; Gannon F Eur J Biochem; 1995 May; 230(1):45-51. PubMed ID: 7541349 [TBL] [Abstract][Full Text] [Related]
19. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. Milne R; Théolis R; Maurice R; Pease RJ; Weech PK; Rassart E; Fruchart JC; Scott J; Marcel YL J Biol Chem; 1989 Nov; 264(33):19754-60. PubMed ID: 2479639 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100. Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]